Global Drug Based on Gene Therapy Market Research Report 2023
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
According to QYResearch’s new survey, global Drug Based on Gene Therapy market is projected to reach US$ 49770 million in 2029, increasing from US$ 9063.6 million in 2022, with the CAGR of 27.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Drug Based on Gene Therapy market research.
The Drug Based on Gene Therapy market is primarily driven by the revolutionary potential of gene therapy to address genetic disorders at their root cause, offering a new paradigm for treating previously incurable conditions. Gene therapy involves introducing genetic material into a patient's cells to correct or replace faulty genes, aiming to restore normal cellular function. The increasing understanding of the genetic basis of diseases, coupled with advancements in gene delivery methods and genome editing techniques, contributes to market growth. Moreover, the demonstrated benefits of gene therapy in providing targeted and long-lasting treatments, overcoming limitations of traditional pharmacological approaches, and offering hope to patients with rare genetic disorders further propel adoption. However, challenges include optimizing gene delivery efficiency, addressing potential immune responses, and ensuring the long-term safety and durability of gene-based treatments. Navigating regulatory pathways, conducting rigorous clinical trials, and addressing ethical considerations are ongoing concerns. The market's success relies on continuous research in genetic medicine, collaborations between biotechnology companies and research institutions, and comprehensive education on the benefits and potential challenges of using gene therapy-based drugs while addressing the evolving challenges associated with precision medicine and personalized treatments.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Drug Based on Gene Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to QYResearch’s new survey, global Drug Based on Gene Therapy market is projected to reach US$ 49770 million in 2029, increasing from US$ 9063.6 million in 2022, with the CAGR of 27.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Drug Based on Gene Therapy market research.
The Drug Based on Gene Therapy market is primarily driven by the revolutionary potential of gene therapy to address genetic disorders at their root cause, offering a new paradigm for treating previously incurable conditions. Gene therapy involves introducing genetic material into a patient's cells to correct or replace faulty genes, aiming to restore normal cellular function. The increasing understanding of the genetic basis of diseases, coupled with advancements in gene delivery methods and genome editing techniques, contributes to market growth. Moreover, the demonstrated benefits of gene therapy in providing targeted and long-lasting treatments, overcoming limitations of traditional pharmacological approaches, and offering hope to patients with rare genetic disorders further propel adoption. However, challenges include optimizing gene delivery efficiency, addressing potential immune responses, and ensuring the long-term safety and durability of gene-based treatments. Navigating regulatory pathways, conducting rigorous clinical trials, and addressing ethical considerations are ongoing concerns. The market's success relies on continuous research in genetic medicine, collaborations between biotechnology companies and research institutions, and comprehensive education on the benefits and potential challenges of using gene therapy-based drugs while addressing the evolving challenges associated with precision medicine and personalized treatments.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Drug Based on Gene Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Biogen
- Novartis
- Gilead Sciences
- Sarepta Therapeutics
- Alnylam Pharmaceuticals
- Amgen
- Spark Therapeutics
- Akcea Therapeutics
- bluebird bio
- Sunway Biotech
- SIBIONO
- AnGes
- Orchard Therapeutics
- Human Stem Cells Institute
- Viral Gene Therapy
- Non-viral Gene Therapy
- Neurological Diseases
- Cancer
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Based on Gene Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Viral Gene Therapy
1.2.3 Non-viral Gene Therapy
1.3 Market by Application
1.3.1 Global Drug Based on Gene Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Drug Based on Gene Therapy Market Perspective (2018-2029)
2.2 Drug Based on Gene Therapy Growth Trends by Region
2.2.1 Global Drug Based on Gene Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Drug Based on Gene Therapy Historic Market Size by Region (2018-2023)
2.2.3 Drug Based on Gene Therapy Forecasted Market Size by Region (2024-2029)
2.3 Drug Based on Gene Therapy Market Dynamics
2.3.1 Drug Based on Gene Therapy Industry Trends
2.3.2 Drug Based on Gene Therapy Market Drivers
2.3.3 Drug Based on Gene Therapy Market Challenges
2.3.4 Drug Based on Gene Therapy Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Drug Based on Gene Therapy Players by Revenue
3.1.1 Global Top Drug Based on Gene Therapy Players by Revenue (2018-2023)
3.1.2 Global Drug Based on Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Drug Based on Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Based on Gene Therapy Revenue
3.4 Global Drug Based on Gene Therapy Market Concentration Ratio
3.4.1 Global Drug Based on Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Based on Gene Therapy Revenue in 2022
3.5 Drug Based on Gene Therapy Key Players Head office and Area Served
3.6 Key Players Drug Based on Gene Therapy Product Solution and Service
3.7 Date of Enter into Drug Based on Gene Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 DRUG BASED ON GENE THERAPY BREAKDOWN DATA BY TYPE
4.1 Global Drug Based on Gene Therapy Historic Market Size by Type (2018-2023)
4.2 Global Drug Based on Gene Therapy Forecasted Market Size by Type (2024-2029)
5 DRUG BASED ON GENE THERAPY BREAKDOWN DATA BY APPLICATION
5.1 Global Drug Based on Gene Therapy Historic Market Size by Application (2018-2023)
5.2 Global Drug Based on Gene Therapy Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Drug Based on Gene Therapy Market Size (2018-2029)
6.2 North America Drug Based on Gene Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Drug Based on Gene Therapy Market Size by Country (2018-2023)
6.4 North America Drug Based on Gene Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Drug Based on Gene Therapy Market Size (2018-2029)
7.2 Europe Drug Based on Gene Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Drug Based on Gene Therapy Market Size by Country (2018-2023)
7.4 Europe Drug Based on Gene Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Drug Based on Gene Therapy Market Size (2018-2029)
8.2 Asia-Pacific Drug Based on Gene Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Drug Based on Gene Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Drug Based on Gene Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Drug Based on Gene Therapy Market Size (2018-2029)
9.2 Latin America Drug Based on Gene Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Drug Based on Gene Therapy Market Size by Country (2018-2023)
9.4 Latin America Drug Based on Gene Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Drug Based on Gene Therapy Market Size (2018-2029)
10.2 Middle East & Africa Drug Based on Gene Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Drug Based on Gene Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Drug Based on Gene Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Biogen
11.1.1 Biogen Company Detail
11.1.2 Biogen Business Overview
11.1.3 Biogen Drug Based on Gene Therapy Introduction
11.1.4 Biogen Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Drug Based on Gene Therapy Introduction
11.2.4 Novartis Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Detail
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Drug Based on Gene Therapy Introduction
11.3.4 Gilead Sciences Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.3.5 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Detail
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Drug Based on Gene Therapy Introduction
11.4.4 Sarepta Therapeutics Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Detail
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Drug Based on Gene Therapy Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Drug Based on Gene Therapy Introduction
11.6.4 Amgen Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.6.5 Amgen Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Detail
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Drug Based on Gene Therapy Introduction
11.7.4 Spark Therapeutics Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.7.5 Spark Therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Detail
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Drug Based on Gene Therapy Introduction
11.8.4 Akcea Therapeutics Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.8.5 Akcea Therapeutics Recent Development
11.9 bluebird bio
11.9.1 bluebird bio Company Detail
11.9.2 bluebird bio Business Overview
11.9.3 bluebird bio Drug Based on Gene Therapy Introduction
11.9.4 bluebird bio Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.9.5 bluebird bio Recent Development
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Detail
11.10.2 Sunway Biotech Business Overview
11.10.3 Sunway Biotech Drug Based on Gene Therapy Introduction
11.10.4 Sunway Biotech Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.10.5 Sunway Biotech Recent Development
11.11 SIBIONO
11.11.1 SIBIONO Company Detail
11.11.2 SIBIONO Business Overview
11.11.3 SIBIONO Drug Based on Gene Therapy Introduction
11.11.4 SIBIONO Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.11.5 SIBIONO Recent Development
11.12 AnGes
11.12.1 AnGes Company Detail
11.12.2 AnGes Business Overview
11.12.3 AnGes Drug Based on Gene Therapy Introduction
11.12.4 AnGes Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.12.5 AnGes Recent Development
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Detail
11.13.2 Orchard Therapeutics Business Overview
11.13.3 Orchard Therapeutics Drug Based on Gene Therapy Introduction
11.13.4 Orchard Therapeutics Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.13.5 Orchard Therapeutics Recent Development
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Detail
11.14.2 Human Stem Cells Institute Business Overview
11.14.3 Human Stem Cells Institute Drug Based on Gene Therapy Introduction
11.14.4 Human Stem Cells Institute Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.14.5 Human Stem Cells Institute Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Based on Gene Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Viral Gene Therapy
1.2.3 Non-viral Gene Therapy
1.3 Market by Application
1.3.1 Global Drug Based on Gene Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Drug Based on Gene Therapy Market Perspective (2018-2029)
2.2 Drug Based on Gene Therapy Growth Trends by Region
2.2.1 Global Drug Based on Gene Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Drug Based on Gene Therapy Historic Market Size by Region (2018-2023)
2.2.3 Drug Based on Gene Therapy Forecasted Market Size by Region (2024-2029)
2.3 Drug Based on Gene Therapy Market Dynamics
2.3.1 Drug Based on Gene Therapy Industry Trends
2.3.2 Drug Based on Gene Therapy Market Drivers
2.3.3 Drug Based on Gene Therapy Market Challenges
2.3.4 Drug Based on Gene Therapy Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Drug Based on Gene Therapy Players by Revenue
3.1.1 Global Top Drug Based on Gene Therapy Players by Revenue (2018-2023)
3.1.2 Global Drug Based on Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Drug Based on Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Based on Gene Therapy Revenue
3.4 Global Drug Based on Gene Therapy Market Concentration Ratio
3.4.1 Global Drug Based on Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Based on Gene Therapy Revenue in 2022
3.5 Drug Based on Gene Therapy Key Players Head office and Area Served
3.6 Key Players Drug Based on Gene Therapy Product Solution and Service
3.7 Date of Enter into Drug Based on Gene Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 DRUG BASED ON GENE THERAPY BREAKDOWN DATA BY TYPE
4.1 Global Drug Based on Gene Therapy Historic Market Size by Type (2018-2023)
4.2 Global Drug Based on Gene Therapy Forecasted Market Size by Type (2024-2029)
5 DRUG BASED ON GENE THERAPY BREAKDOWN DATA BY APPLICATION
5.1 Global Drug Based on Gene Therapy Historic Market Size by Application (2018-2023)
5.2 Global Drug Based on Gene Therapy Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Drug Based on Gene Therapy Market Size (2018-2029)
6.2 North America Drug Based on Gene Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Drug Based on Gene Therapy Market Size by Country (2018-2023)
6.4 North America Drug Based on Gene Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Drug Based on Gene Therapy Market Size (2018-2029)
7.2 Europe Drug Based on Gene Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Drug Based on Gene Therapy Market Size by Country (2018-2023)
7.4 Europe Drug Based on Gene Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Drug Based on Gene Therapy Market Size (2018-2029)
8.2 Asia-Pacific Drug Based on Gene Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Drug Based on Gene Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Drug Based on Gene Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Drug Based on Gene Therapy Market Size (2018-2029)
9.2 Latin America Drug Based on Gene Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Drug Based on Gene Therapy Market Size by Country (2018-2023)
9.4 Latin America Drug Based on Gene Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Drug Based on Gene Therapy Market Size (2018-2029)
10.2 Middle East & Africa Drug Based on Gene Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Drug Based on Gene Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Drug Based on Gene Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Biogen
11.1.1 Biogen Company Detail
11.1.2 Biogen Business Overview
11.1.3 Biogen Drug Based on Gene Therapy Introduction
11.1.4 Biogen Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Drug Based on Gene Therapy Introduction
11.2.4 Novartis Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Detail
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Drug Based on Gene Therapy Introduction
11.3.4 Gilead Sciences Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.3.5 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Detail
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Drug Based on Gene Therapy Introduction
11.4.4 Sarepta Therapeutics Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Detail
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Drug Based on Gene Therapy Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Drug Based on Gene Therapy Introduction
11.6.4 Amgen Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.6.5 Amgen Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Detail
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Drug Based on Gene Therapy Introduction
11.7.4 Spark Therapeutics Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.7.5 Spark Therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Detail
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Drug Based on Gene Therapy Introduction
11.8.4 Akcea Therapeutics Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.8.5 Akcea Therapeutics Recent Development
11.9 bluebird bio
11.9.1 bluebird bio Company Detail
11.9.2 bluebird bio Business Overview
11.9.3 bluebird bio Drug Based on Gene Therapy Introduction
11.9.4 bluebird bio Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.9.5 bluebird bio Recent Development
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Detail
11.10.2 Sunway Biotech Business Overview
11.10.3 Sunway Biotech Drug Based on Gene Therapy Introduction
11.10.4 Sunway Biotech Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.10.5 Sunway Biotech Recent Development
11.11 SIBIONO
11.11.1 SIBIONO Company Detail
11.11.2 SIBIONO Business Overview
11.11.3 SIBIONO Drug Based on Gene Therapy Introduction
11.11.4 SIBIONO Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.11.5 SIBIONO Recent Development
11.12 AnGes
11.12.1 AnGes Company Detail
11.12.2 AnGes Business Overview
11.12.3 AnGes Drug Based on Gene Therapy Introduction
11.12.4 AnGes Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.12.5 AnGes Recent Development
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Detail
11.13.2 Orchard Therapeutics Business Overview
11.13.3 Orchard Therapeutics Drug Based on Gene Therapy Introduction
11.13.4 Orchard Therapeutics Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.13.5 Orchard Therapeutics Recent Development
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Detail
11.14.2 Human Stem Cells Institute Business Overview
11.14.3 Human Stem Cells Institute Drug Based on Gene Therapy Introduction
11.14.4 Human Stem Cells Institute Revenue in Drug Based on Gene Therapy Business (2018-2023)
11.14.5 Human Stem Cells Institute Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Drug Based on Gene Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Viral Gene Therapy
Table 3. Key Players of Non-viral Gene Therapy
Table 4. Global Drug Based on Gene Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Drug Based on Gene Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Drug Based on Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Drug Based on Gene Therapy Market Share by Region (2018-2023)
Table 8. Global Drug Based on Gene Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Drug Based on Gene Therapy Market Share by Region (2024-2029)
Table 10. Drug Based on Gene Therapy Market Trends
Table 11. Drug Based on Gene Therapy Market Drivers
Table 12. Drug Based on Gene Therapy Market Challenges
Table 13. Drug Based on Gene Therapy Market Restraints
Table 14. Global Drug Based on Gene Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Drug Based on Gene Therapy Market Share by Players (2018-2023)
Table 16. Global Top Drug Based on Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Based on Gene Therapy as of 2022)
Table 17. Ranking of Global Top Drug Based on Gene Therapy Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Drug Based on Gene Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Drug Based on Gene Therapy Product Solution and Service
Table 21. Date of Enter into Drug Based on Gene Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug Based on Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Drug Based on Gene Therapy Revenue Market Share by Type (2018-2023)
Table 25. Global Drug Based on Gene Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Drug Based on Gene Therapy Revenue Market Share by Type (2024-2029)
Table 27. Global Drug Based on Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Drug Based on Gene Therapy Revenue Market Share by Application (2018-2023)
Table 29. Global Drug Based on Gene Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Drug Based on Gene Therapy Revenue Market Share by Application (2024-2029)
Table 31. North America Drug Based on Gene Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Drug Based on Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Drug Based on Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Drug Based on Gene Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Drug Based on Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Drug Based on Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Drug Based on Gene Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Drug Based on Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Drug Based on Gene Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Drug Based on Gene Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Drug Based on Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Drug Based on Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Drug Based on Gene Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Drug Based on Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Drug Based on Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 46. Biogen Company Detail
Table 47. Biogen Business Overview
Table 48. Biogen Drug Based on Gene Therapy Product
Table 49. Biogen Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 50. Biogen Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Drug Based on Gene Therapy Product
Table 54. Novartis Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Gilead Sciences Company Detail
Table 57. Gilead Sciences Business Overview
Table 58. Gilead Sciences Drug Based on Gene Therapy Product
Table 59. Gilead Sciences Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 60. Gilead Sciences Recent Development
Table 61. Sarepta Therapeutics Company Detail
Table 62. Sarepta Therapeutics Business Overview
Table 63. Sarepta Therapeutics Drug Based on Gene Therapy Product
Table 64. Sarepta Therapeutics Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 65. Sarepta Therapeutics Recent Development
Table 66. Alnylam Pharmaceuticals Company Detail
Table 67. Alnylam Pharmaceuticals Business Overview
Table 68. Alnylam Pharmaceuticals Drug Based on Gene Therapy Product
Table 69. Alnylam Pharmaceuticals Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 70. Alnylam Pharmaceuticals Recent Development
Table 71. Amgen Company Detail
Table 72. Amgen Business Overview
Table 73. Amgen Drug Based on Gene Therapy Product
Table 74. Amgen Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. Spark Therapeutics Company Detail
Table 77. Spark Therapeutics Business Overview
Table 78. Spark Therapeutics Drug Based on Gene Therapy Product
Table 79. Spark Therapeutics Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 80. Spark Therapeutics Recent Development
Table 81. Akcea Therapeutics Company Detail
Table 82. Akcea Therapeutics Business Overview
Table 83. Akcea Therapeutics Drug Based on Gene Therapy Product
Table 84. Akcea Therapeutics Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 85. Akcea Therapeutics Recent Development
Table 86. bluebird bio Company Detail
Table 87. bluebird bio Business Overview
Table 88. bluebird bio Drug Based on Gene Therapy Product
Table 89. bluebird bio Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 90. bluebird bio Recent Development
Table 91. Sunway Biotech Company Detail
Table 92. Sunway Biotech Business Overview
Table 93. Sunway Biotech Drug Based on Gene Therapy Product
Table 94. Sunway Biotech Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 95. Sunway Biotech Recent Development
Table 96. SIBIONO Company Detail
Table 97. SIBIONO Business Overview
Table 98. SIBIONO Drug Based on Gene Therapy Product
Table 99. SIBIONO Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 100. SIBIONO Recent Development
Table 101. AnGes Company Detail
Table 102. AnGes Business Overview
Table 103. AnGes Drug Based on Gene Therapy Product
Table 104. AnGes Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 105. AnGes Recent Development
Table 106. Orchard Therapeutics Company Detail
Table 107. Orchard Therapeutics Business Overview
Table 108. Orchard Therapeutics Drug Based on Gene Therapy Product
Table 109. Orchard Therapeutics Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 110. Orchard Therapeutics Recent Development
Table 111. Human Stem Cells Institute Company Detail
Table 112. Human Stem Cells Institute Business Overview
Table 113. Human Stem Cells Institute Drug Based on Gene Therapy Product
Table 114. Human Stem Cells Institute Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 115. Human Stem Cells Institute Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 1. Global Drug Based on Gene Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Viral Gene Therapy
Table 3. Key Players of Non-viral Gene Therapy
Table 4. Global Drug Based on Gene Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Drug Based on Gene Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Drug Based on Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Drug Based on Gene Therapy Market Share by Region (2018-2023)
Table 8. Global Drug Based on Gene Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Drug Based on Gene Therapy Market Share by Region (2024-2029)
Table 10. Drug Based on Gene Therapy Market Trends
Table 11. Drug Based on Gene Therapy Market Drivers
Table 12. Drug Based on Gene Therapy Market Challenges
Table 13. Drug Based on Gene Therapy Market Restraints
Table 14. Global Drug Based on Gene Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Drug Based on Gene Therapy Market Share by Players (2018-2023)
Table 16. Global Top Drug Based on Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Based on Gene Therapy as of 2022)
Table 17. Ranking of Global Top Drug Based on Gene Therapy Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Drug Based on Gene Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Drug Based on Gene Therapy Product Solution and Service
Table 21. Date of Enter into Drug Based on Gene Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug Based on Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Drug Based on Gene Therapy Revenue Market Share by Type (2018-2023)
Table 25. Global Drug Based on Gene Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Drug Based on Gene Therapy Revenue Market Share by Type (2024-2029)
Table 27. Global Drug Based on Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Drug Based on Gene Therapy Revenue Market Share by Application (2018-2023)
Table 29. Global Drug Based on Gene Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Drug Based on Gene Therapy Revenue Market Share by Application (2024-2029)
Table 31. North America Drug Based on Gene Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Drug Based on Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Drug Based on Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Drug Based on Gene Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Drug Based on Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Drug Based on Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Drug Based on Gene Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Drug Based on Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Drug Based on Gene Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Drug Based on Gene Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Drug Based on Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Drug Based on Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Drug Based on Gene Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Drug Based on Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Drug Based on Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 46. Biogen Company Detail
Table 47. Biogen Business Overview
Table 48. Biogen Drug Based on Gene Therapy Product
Table 49. Biogen Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 50. Biogen Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Drug Based on Gene Therapy Product
Table 54. Novartis Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Gilead Sciences Company Detail
Table 57. Gilead Sciences Business Overview
Table 58. Gilead Sciences Drug Based on Gene Therapy Product
Table 59. Gilead Sciences Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 60. Gilead Sciences Recent Development
Table 61. Sarepta Therapeutics Company Detail
Table 62. Sarepta Therapeutics Business Overview
Table 63. Sarepta Therapeutics Drug Based on Gene Therapy Product
Table 64. Sarepta Therapeutics Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 65. Sarepta Therapeutics Recent Development
Table 66. Alnylam Pharmaceuticals Company Detail
Table 67. Alnylam Pharmaceuticals Business Overview
Table 68. Alnylam Pharmaceuticals Drug Based on Gene Therapy Product
Table 69. Alnylam Pharmaceuticals Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 70. Alnylam Pharmaceuticals Recent Development
Table 71. Amgen Company Detail
Table 72. Amgen Business Overview
Table 73. Amgen Drug Based on Gene Therapy Product
Table 74. Amgen Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. Spark Therapeutics Company Detail
Table 77. Spark Therapeutics Business Overview
Table 78. Spark Therapeutics Drug Based on Gene Therapy Product
Table 79. Spark Therapeutics Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 80. Spark Therapeutics Recent Development
Table 81. Akcea Therapeutics Company Detail
Table 82. Akcea Therapeutics Business Overview
Table 83. Akcea Therapeutics Drug Based on Gene Therapy Product
Table 84. Akcea Therapeutics Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 85. Akcea Therapeutics Recent Development
Table 86. bluebird bio Company Detail
Table 87. bluebird bio Business Overview
Table 88. bluebird bio Drug Based on Gene Therapy Product
Table 89. bluebird bio Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 90. bluebird bio Recent Development
Table 91. Sunway Biotech Company Detail
Table 92. Sunway Biotech Business Overview
Table 93. Sunway Biotech Drug Based on Gene Therapy Product
Table 94. Sunway Biotech Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 95. Sunway Biotech Recent Development
Table 96. SIBIONO Company Detail
Table 97. SIBIONO Business Overview
Table 98. SIBIONO Drug Based on Gene Therapy Product
Table 99. SIBIONO Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 100. SIBIONO Recent Development
Table 101. AnGes Company Detail
Table 102. AnGes Business Overview
Table 103. AnGes Drug Based on Gene Therapy Product
Table 104. AnGes Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 105. AnGes Recent Development
Table 106. Orchard Therapeutics Company Detail
Table 107. Orchard Therapeutics Business Overview
Table 108. Orchard Therapeutics Drug Based on Gene Therapy Product
Table 109. Orchard Therapeutics Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 110. Orchard Therapeutics Recent Development
Table 111. Human Stem Cells Institute Company Detail
Table 112. Human Stem Cells Institute Business Overview
Table 113. Human Stem Cells Institute Drug Based on Gene Therapy Product
Table 114. Human Stem Cells Institute Revenue in Drug Based on Gene Therapy Business (2018-2023) & (US$ Million)
Table 115. Human Stem Cells Institute Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Drug Based on Gene Therapy Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Drug Based on Gene Therapy Market Share by Type: 2022 VS 2029
Figure 3. Viral Gene Therapy Features
Figure 4. Non-viral Gene Therapy Features
Figure 5. Global Drug Based on Gene Therapy Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Drug Based on Gene Therapy Market Share by Application: 2022 VS 2029
Figure 7. Neurological Diseases Case Studies
Figure 8. Cancer Case Studies
Figure 9. Other Case Studies
Figure 10. Drug Based on Gene Therapy Report Years Considered
Figure 11. Global Drug Based on Gene Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Drug Based on Gene Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Drug Based on Gene Therapy Market Share by Region: 2022 VS 2029
Figure 14. Global Drug Based on Gene Therapy Market Share by Players in 2022
Figure 15. Global Top Drug Based on Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Based on Gene Therapy as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Drug Based on Gene Therapy Revenue in 2022
Figure 17. North America Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Drug Based on Gene Therapy Market Share by Country (2018-2029)
Figure 19. United States Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Drug Based on Gene Therapy Market Share by Country (2018-2029)
Figure 23. Germany Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Drug Based on Gene Therapy Market Share by Region (2018-2029)
Figure 31. China Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Drug Based on Gene Therapy Market Share by Country (2018-2029)
Figure 39. Mexico Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Drug Based on Gene Therapy Market Share by Country (2018-2029)
Figure 43. Turkey Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Biogen Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 46. Novartis Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 47. Gilead Sciences Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 48. Sarepta Therapeutics Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 49. Alnylam Pharmaceuticals Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 50. Amgen Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 51. Spark Therapeutics Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 52. Akcea Therapeutics Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 53. bluebird bio Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 54. Sunway Biotech Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 55. SIBIONO Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 56. AnGes Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 57. Orchard Therapeutics Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 58. Human Stem Cells Institute Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Figure 1. Global Drug Based on Gene Therapy Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Drug Based on Gene Therapy Market Share by Type: 2022 VS 2029
Figure 3. Viral Gene Therapy Features
Figure 4. Non-viral Gene Therapy Features
Figure 5. Global Drug Based on Gene Therapy Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Drug Based on Gene Therapy Market Share by Application: 2022 VS 2029
Figure 7. Neurological Diseases Case Studies
Figure 8. Cancer Case Studies
Figure 9. Other Case Studies
Figure 10. Drug Based on Gene Therapy Report Years Considered
Figure 11. Global Drug Based on Gene Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Drug Based on Gene Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Drug Based on Gene Therapy Market Share by Region: 2022 VS 2029
Figure 14. Global Drug Based on Gene Therapy Market Share by Players in 2022
Figure 15. Global Top Drug Based on Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Based on Gene Therapy as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Drug Based on Gene Therapy Revenue in 2022
Figure 17. North America Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Drug Based on Gene Therapy Market Share by Country (2018-2029)
Figure 19. United States Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Drug Based on Gene Therapy Market Share by Country (2018-2029)
Figure 23. Germany Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Drug Based on Gene Therapy Market Share by Region (2018-2029)
Figure 31. China Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Drug Based on Gene Therapy Market Share by Country (2018-2029)
Figure 39. Mexico Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Drug Based on Gene Therapy Market Share by Country (2018-2029)
Figure 43. Turkey Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Drug Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Biogen Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 46. Novartis Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 47. Gilead Sciences Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 48. Sarepta Therapeutics Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 49. Alnylam Pharmaceuticals Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 50. Amgen Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 51. Spark Therapeutics Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 52. Akcea Therapeutics Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 53. bluebird bio Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 54. Sunway Biotech Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 55. SIBIONO Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 56. AnGes Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 57. Orchard Therapeutics Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 58. Human Stem Cells Institute Revenue Growth Rate in Drug Based on Gene Therapy Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
